Clinical and Molecular Predictors of Local Failure After SBRT for Liver Metastases: A Secondary Analysis of a Prospective Phase II Trial

被引：2
|
作者：
Wo, J. Y. [1 ]
Zhu, A. X. [2 ]
McDonnell, E. I. [2 ]
Yeap, B. [2 ]
Borger, D. R. [2 ]
Iafrate, A. [2 ]
Drapek, L. C. [2 ]
Blaszkowsky, L. S. [2 ]
Kwak, E. L. [2 ]
Clark, J. [2 ]
Goyal, L. [2 ]
Allen, J. N. [2 ]
Ryan, D. P. [2 ]
Arellano, R. [2 ]
Wolfgang, J. A. [1 ]
Mullen, J. T. [2 ]
Mamon, H. J. [3 ]
DeLaney, T. F. [2 ]
Hong, T. S. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
253
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [21] Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-institutional Trial
    Wang, K.
    Chen, R. C.
    Kane, B. L.
    Medbery, C. A., III
    Underhill, K., Jr.
    Gray, J. R.
    Peddada, A. V.
    Fuller, D. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S34 - S34
  • [22] Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial
    Baker, Sarah
    Mou, Benjamin
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah M.
    Schellenberg, Devin
    Alexander, Abraham S.
    Carolan, Hannah
    Atrchian, Siavash
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Tyldesley, Scott
    Olson, Robert A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 856 - 861
  • [23] Local therapy for oligometastatic esophageal squamous cell carcinoma: a prospective, randomized, Phase II clinical trial
    Liu, Qi
    Chen, Junqiang
    Li, Baosheng
    Ye, Jinjun
    Wei, Shihong
    Wang, Yaohui
    Yang, Huanjun
    Zhu, Zhengfei
    Lai, Songtao
    Li, Ling
    Chen, Yun
    Wang, Jialei
    Xiang, Jiaqing
    Zhao, Kuaile
    FUTURE ONCOLOGY, 2021, 17 (11) : 1285 - 1293
  • [24] A Phase II/III clinical trial interim analysis of PERV transmissibility to acute liver failure patients treated with a porcine based bioartificial liver
    Pitkin, Z
    Switzer, WM
    Shanmugam, V
    Stevens, AC
    Solomon, BA
    Chapman, L
    Bhullar, V
    Hussain, A
    Matthews, A
    Sandstrom, P
    Mullon, CJP
    Heneine, W
    XENOTRANSPLANTATION, 2001, 8 : 34 - 34
  • [25] THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)
    Robinson, Giles W.
    Rudneva, Vasilisa A.
    Buchhalter, Ivo
    Billups, Catherine A.
    Waszak, Sebastian M.
    Smith, Kyle
    Bowers, Daniel C.
    Bendel, Anne
    Fisher, Paul
    Partap, Sonia
    Crawford, John
    Hassall, Tim
    Indelicato, Daniel J.
    Boop, Frederick
    Klimo, Paul
    Sabin, Noah D.
    Patay, Zoltan
    Merchant, Thomas E.
    Stewart, Clinton F.
    Orr, Brent A.
    Korbel, Jan O.
    Jones, David T. W.
    Sharma, Tanvi
    Lichter, Peter
    Kool, Marcel
    Korshunov, Andrey
    Pfister, Stefan M.
    Gilbertson, Richard J.
    Sanders, Robert P.
    Onar-Thomas, Arzu
    Ellison, David W.
    Gajjar, Amar
    Northcott, Paul A.
    NEURO-ONCOLOGY, 2018, 20 : 126 - 127
  • [26] HDR-BT plus SBRT for prostate cancer. QoL and toxicity analysis in a prospective phase II trial.
    Buchser, D.
    Bilbal, A.
    Mayrata, E.
    Perez, F.
    Espinosa, J. M.
    Valverde, I.
    Santos, B.
    Casquero, F.
    Gomez-Iturriaga, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S39 - S640
  • [27] Temsirolimus in Metastatic Urothelial Cancer After Platin-Failure: A Phase II Clinical Trial
    Gerullis, H.
    Eimer, C.
    Georgas, E.
    Otto, T.
    UROLOGY, 2012, 80 (03) : S205 - S205
  • [28] A PROSPECTIVE PHASE-II CLINICAL-TRIAL OF CONTINUOUS FUDR REGIONAL CHEMOTHERAPY FOR COLORECTAL METASTASES TO THE LIVER USING A TOTALLY IMPLANTABLE DRUG INFUSION PUMP
    BALCH, CM
    URIST, MM
    SOONG, SJ
    MCGREGOR, M
    ANNALS OF SURGERY, 1983, 198 (05) : 567 - 573
  • [29] Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
    Azhie, Amirhossein
    Grant, Robert C.
    Herman, Michael
    Wang, Lisa
    Knox, Jennifer J.
    Bhat, Mamatha
    FUTURE ONCOLOGY, 2022, 18 (18) : 2173 - 2191
  • [30] A PHASE II MULTICENTRIC PROSPECTIVE TRIAL ON HEPATIC ARTERIAL YTTHRIUM MICROSPHERES AS SALVAGE THERAPY IN UNRESECTABLE, CHEMOREFRACTORY COLORECTAL LIVER METASTASES
    Cosimelli, Maurizio
    Cagol, Pierpaolo
    Carpanese, Livio
    Fiore, Francesco
    Gasparini, Daniele
    Geatti, Onelio
    Golfieri, Rita
    Izzo, Francesco
    Sciuto, Rosa
    Maini, Carlo L.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3246 - 3246
12345